The Motley Fool
16 Nov 2026, 11:36 UTC · 14h ago
CME vs. Morningstar: Which Financial Stock Is a Better Buy for 2027?
Impact · against what's priced in
The article provides no new catalysts for CME or GOOGL, as the financial performance and partnerships mentioned are already reflected in their current valuations. Morningstar's brand authority and diversified customer base are noted as strengths, though they lack a specific valuation baseline for precise impact assessment.
- CME+0.00
Already priced in
- The price assumes
The current 64.3% free-cash-flow margin and 86.1% gross margin sustained indefinitely





